350 related articles for article (PubMed ID: 21134046)
21. [Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique].
Prager W; Wissmüller E; Kollhorst B; Böer A; Zschocke I
Hautarzt; 2011 May; 62(5):375-9. PubMed ID: 21503782
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin in the lower one third of the face.
Atamoros FP
Clin Dermatol; 2003; 21(6):505-12. PubMed ID: 14759584
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin A treatment of perioral rhytides.
Semchyshyn N; Sengelmann RD
Dermatol Surg; 2003 May; 29(5):490-5; discussion 495. PubMed ID: 12752516
[TBL] [Abstract][Full Text] [Related]
24. Commentary: Efficacy and safety of a novel botulinum toxin topical gel.
West TB
Dermatol Surg; 2010 Dec; 36 Suppl 4():2119-20. PubMed ID: 21244565
[No Abstract] [Full Text] [Related]
25. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study.
Elridy AS; Zaki RGE; Elshinawy RF
Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961
[TBL] [Abstract][Full Text] [Related]
27. Prospective Randomized Split-Face Comparative Study Between Topical Botulinum Toxin A Surface Application and Local Injection for Crow's Feet.
Mahmoud BH; Ozog D; Burnett C; Cohen JL
Dermatol Surg; 2016 Apr; 42(4):554-6. PubMed ID: 26990256
[No Abstract] [Full Text] [Related]
28. [Botulinum toxin A in the treatment of wrinkles in the upper third of the face].
Gassia V
Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S299-305. PubMed ID: 19931689
[TBL] [Abstract][Full Text] [Related]
29. The use of botulinum toxin type A in cosmetic facial procedures.
Jaspers GW; Pijpe J; Jansma J
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
[TBL] [Abstract][Full Text] [Related]
30. [Botulinum: fashionable drug and effective medication. What the "miracle weapon against crow's feet" can do in addition].
Stiefelhagen P
MMW Fortschr Med; 2003 Apr; 145(14):4-6. PubMed ID: 15072266
[No Abstract] [Full Text] [Related]
31. Full-face injections of variable total doses of abobotulinum toxin type A: A randomized, phase IV clinical trial of safety and efficacy.
Hexsel D; Brum C; Porto MD; Soirefmann M; Siega C; Schilling-Souza J; Rodrigues TC
J Drugs Dermatol; 2013 Dec; 12(12):1356-62. PubMed ID: 24301236
[TBL] [Abstract][Full Text] [Related]
32. Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A.
Schlessinger J; Monheit G; Kane MA; Mendelsohn N
Dermatol Surg; 2011 Oct; 37(10):1434-42. PubMed ID: 21745254
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
Hui JI; Lee WW
Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study.
Levy JL; Servant JJ; Jouve E
J Cosmet Laser Ther; 2004 May; 6(1):16-20. PubMed ID: 15370408
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneous crow's feet line patterns and customized botulinum toxin rejuvenating treatment.
Cavallini M; Papagni M; Augelli F; Muti GF; Santorelli A; Raichi M
J Cosmet Dermatol; 2022 Oct; 21(10):4294-4300. PubMed ID: 35723939
[TBL] [Abstract][Full Text] [Related]
36. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
Arat YO; Yen MT
Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
[TBL] [Abstract][Full Text] [Related]
37. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.
Nettar KD; Yu KC; Bapna S; Boscardin J; Maas CS
Arch Facial Plast Surg; 2011; 13(6):380-6. PubMed ID: 21690460
[TBL] [Abstract][Full Text] [Related]
38. [Botulinum toxin A in the treatment of the wrinkles in the upper third of the face].
Gassia V
Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S175-80. PubMed ID: 18342124
[TBL] [Abstract][Full Text] [Related]
39. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
[TBL] [Abstract][Full Text] [Related]
40. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications.
Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H
Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
